NASDAQ:GTHX - G1 Therapeutics News Headlines

$26.49
-0.65 (-2.39 %)
(As of 07/16/2019 10:07 AM ET)
Today's Range
$26.43
Now: $26.49
$26.96
50-Day Range
$18.44
MA: $24.47
$30.81
52-Week Range
$13.87
Now: $26.49
$69.57
Volume539 shs
Average Volume674,457 shs
Market Capitalization$992.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.68

Headlines

G1 Therapeutics (NASDAQ GTHX) News Headlines

Source:
DateHeadline
GTHX Crosses Below Key Moving Average LevelGTHX Crosses Below Key Moving Average Level
www.nasdaq.com - July 8 at 5:25 PM
Comparing G1 Therapeutics (NASDAQ:GTHX) and Bio-Path (NASDAQ:BPTH)Comparing G1 Therapeutics (NASDAQ:GTHX) and Bio-Path (NASDAQ:BPTH)
www.americanbankingnews.com - July 2 at 4:08 AM
Did Hedge Funds Drop The Ball On G1 Therapeutics, Inc. (GTHX) ?Did Hedge Funds Drop The Ball On G1 Therapeutics, Inc. (GTHX) ?
finance.yahoo.com - June 29 at 9:35 AM
G1 Therapeutics Inc (NASDAQ:GTHX) Short Interest UpdateG1 Therapeutics Inc (NASDAQ:GTHX) Short Interest Update
www.americanbankingnews.com - June 29 at 5:20 AM
-$0.73 EPS Expected for G1 Therapeutics Inc (NASDAQ:GTHX) This Quarter-$0.73 EPS Expected for G1 Therapeutics Inc (NASDAQ:GTHX) This Quarter
www.americanbankingnews.com - June 24 at 2:14 PM
These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?
finance.yahoo.com - June 23 at 9:46 AM
G1 Therapeutics Inc (NASDAQ:GTHX) Receives Average Rating of "Buy" from AnalystsG1 Therapeutics Inc (NASDAQ:GTHX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 22 at 4:33 AM
G1 Therapeutics Inc Forecasted to Earn FY2019 Earnings of ($2.96) Per Share (NASDAQ:GTHX)G1 Therapeutics Inc Forecasted to Earn FY2019 Earnings of ($2.96) Per Share (NASDAQ:GTHX)
www.americanbankingnews.com - June 21 at 7:37 AM
Why new cancer trial data is good news for a Triangle pharmaWhy new cancer trial data is good news for a Triangle pharma
www.bizjournals.com - June 19 at 6:04 PM
Company News For Jun 19, 2019Company News For Jun 19, 2019
finance.yahoo.com - June 19 at 11:42 AM
Whats Behind The Rally In Small-Cap Biotech G1 Therapeutics?What's Behind The Rally In Small-Cap Biotech G1 Therapeutics?
www.benzinga.com - June 18 at 6:10 PM
G1 Therapeutics says breast cancer treatment helped extend life in studyG1 Therapeutics says breast cancer treatment helped extend life in study
seekingalpha.com - June 18 at 6:10 PM
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual MeetingG1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
finance.yahoo.com - June 14 at 11:36 AM
G1 Therapeutics Announces Updates to Board of DirectorsG1 Therapeutics Announces Updates to Board of Directors
finance.yahoo.com - June 13 at 10:02 AM
G1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinical Oncology (ASCO) Annual MeetingG1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - June 1 at 4:40 PM
G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual MeetingG1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - May 16 at 11:20 AM
G1 Therapeutics, Inc. (GTHX) Q1 2019 Earnings Call TranscriptG1 Therapeutics, Inc. (GTHX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 13 at 6:22 PM
G1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q1 2019 Results - Earnings Call TranscriptG1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 13 at 9:49 AM
G1 Therapeutics to Present at UBS Global Healthcare ConferenceG1 Therapeutics to Present at UBS Global Healthcare Conference
finance.yahoo.com - May 13 at 9:49 AM
Imagine Owning G1 Therapeutics (NASDAQ:GTHX) And Wondering If The 48% Share Price Slide Is JustifiedImagine Owning G1 Therapeutics (NASDAQ:GTHX) And Wondering If The 48% Share Price Slide Is Justified
finance.yahoo.com - May 12 at 9:41 AM
Edited Transcript of GTHX.O earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of GTHX.O earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 9:46 AM
G1 Therapeutics Provides First Quarter 2019 Corporate and Financial UpdateG1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update
finance.yahoo.com - May 9 at 6:10 PM
G1 Therapeutics Looks To Regulatory Agency For Its Bone Marrow Preservation DrugG1 Therapeutics Looks To Regulatory Agency For Its Bone Marrow Preservation Drug
seekingalpha.com - May 7 at 5:51 PM
Here’s What Hedge Funds Think About G1 Therapeutics, Inc. (GTHX)Here’s What Hedge Funds Think About G1 Therapeutics, Inc. (GTHX)
finance.yahoo.com - May 6 at 9:47 AM
G1 Therapeutics aims to expand as it approaches NDA filingG1 Therapeutics aims to expand as it approaches NDA filing
finance.yahoo.com - May 2 at 9:49 AM
G1 Therapeutics to Report First Quarter Financial Results on May 9, 2019G1 Therapeutics to Report First Quarter Financial Results on May 9, 2019
finance.yahoo.com - May 2 at 9:49 AM
G1 Therapeutics to grow as it approaches filing NDAG1 Therapeutics to grow as it approaches filing NDA
finance.yahoo.com - May 1 at 6:04 PM
G1 Therapeutics Inc.G1 Therapeutics Inc.
www.barrons.com - April 30 at 5:48 PM
G1 Therapeutics Hits Its Highest Level Of 2019: What You Need To KnowG1 Therapeutics Hits Its Highest Level Of 2019: What You Need To Know
finance.yahoo.com - April 30 at 5:48 PM
Why G1 Therapeutics Is Soaring 16% TodayWhy G1 Therapeutics Is Soaring 16% Today
finance.yahoo.com - April 30 at 5:48 PM
G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
www.globenewswire.com - April 29 at 5:34 PM
G1 on go with marketing applications for trilaciclibG1 on go with marketing applications for trilaciclib
seekingalpha.com - April 29 at 5:34 PM
G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
finance.yahoo.com - April 29 at 5:34 PM
G1 Therapeutics stock rallies 25%; company to file application for new cancer drugG1 Therapeutics stock rallies 25%; company to file application for new cancer drug
finance.yahoo.com - April 29 at 5:34 PM
G1 Therapeutics to Present at the 18th Annual Needham Healthcare ConferenceG1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
finance.yahoo.com - April 2 at 12:16 PM
G1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q4 2018 Results - Earnings Call TranscriptG1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 5:06 PM
Edited Transcript of GTHX.O earnings conference call or presentation 28-Feb-19 9:30pm GMTEdited Transcript of GTHX.O earnings conference call or presentation 28-Feb-19 9:30pm GMT
finance.yahoo.com - March 2 at 9:29 AM
G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial ResultsG1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - February 28 at 5:54 PM
G1 Therapeutics to Host Investor Day 2019 on March 6, 2019G1 Therapeutics to Host Investor Day 2019 on March 6, 2019
finance.yahoo.com - February 27 at 9:55 AM
Are Insiders Selling G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock?Are Insiders Selling G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock?
finance.yahoo.com - February 11 at 11:10 AM
G1 Therapeutics (GTHX) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowG1 Therapeutics (GTHX) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 9 at 5:39 PM
G1 THERAPEUTICS Enters Oversold TerritoryG1 THERAPEUTICS Enters Oversold Territory
finance.yahoo.com - January 7 at 9:31 AM
G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare ConferenceG1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
www.nasdaq.com - December 27 at 9:46 AM
Raymond James Keeps Bullish View on Biotech G1 After 43% SlideRaymond James Keeps Bullish View on Biotech G1 After 43% Slide
finance.yahoo.com - December 21 at 4:34 PM
G1 Therapeutics Investors Recoil, Analysts Bullish In Wake Of Trilaciclib ResultsG1 Therapeutics Investors Recoil, Analysts Bullish In Wake Of Trilaciclib Results
feeds.benzinga.com - December 20 at 11:22 AM
G1 Therapeutics trilaciclib fails to beat placebo in mid-stage lung cancer study; shares down 24% after hoursG1 Therapeutics' trilaciclib fails to beat placebo in mid-stage lung cancer study; shares down 24% after hours
seekingalpha.com - December 20 at 9:43 AM
G1 Therapeutics stock dives on cancer-related infection drug study resultsG1 Therapeutics stock dives on cancer-related infection drug study results
finance.yahoo.com - December 20 at 9:43 AM
G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung CancerG1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer
finance.yahoo.com - December 19 at 4:45 PM
G1 Therapeutics cancer-related infection drug passes clinical studyG1 Therapeutics cancer-related infection drug passes clinical study
finance.yahoo.com - December 19 at 4:45 PM
G1 Therapeutics, Inc. (GTHX): Are Hedge Funds Right About This Stock?G1 Therapeutics, Inc. (GTHX): Are Hedge Funds Right About This Stock?
finance.yahoo.com - December 15 at 4:28 PM
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel